PATENT CLAIM ANALYSIS

Application Number: 15761012
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "190100"]

Abstract:
The present invention provides antigens, for use in the treatment or prevention of  C. burnetii  infection. Also provided are nucleic acids encoding such antigens, and antibodies raised against such antigens.

Claim (Index 42):
A method for producing an antibody, said method comprising the following steps:\n (a) contacting a B cell with an effective amount of at least one protein antigen according to  claim 1 ; (b) fusing the B cell of step (a) with a myeloma cell to obtain a hybridoma cell; and (c) isolating the antibody produced by the cultivated hybridoma cell.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 90.0
- Lexical Diversity: 1.17241
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12557741', '11837264', '12614896', '14396881', '12988595']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.686152379198741
- 35 USC 102 Novelty (BERT): 0.5078697666709773
- Combined Prediction Score: 0.6683241179459646
- Mean Citation Score: 259.467096
- Max Citation Score: 263.20352
- Similarity Product: 195.75055205619813

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test